BPC-157 · Tendinopathy
Suggestive in animal models. Human evidence remains thin.
Human-reviewed · Dr. M. Chen · 2026-04-12
The pen makes injections easy.
The platform makes results measured.
Three minutes a day. Twelve sites tracked. Citations on every answer. One chart your clinician can actually read.
Conduit makes the apparatus and the intelligence. You source the peptide.
Today · Day 27
BPC-157 · 250 mcg · daily am.
Ready when you are
Three minutes.
Next site: Right thigh, outer.
The Daily Ritual home · live preview
The pen removes the anxiety of the act. The platform removes the doubt about the outcome. Neither half does both alone.
The pen alone
What it’s missing
The platform alone
What it’s missing
Pen + Platform
That’s the loop. That’s why both.
The app already knows it's Day 27 of your protocol, which thigh is fresh, and exactly how many units to dial.
Eight steps. Three minutes. The protocol becomes a practice.
01 · The Daily Ritual
Today · Day 27
BPC-157 · 250 mcg · daily am.
Ready when you are
Three minutes.
Next site: Right thigh, outer.
Right thigh, outer.
Recommended · 9 days clean
11:08 PM
“Is 5 mg of BPC-157 a single weekly dose, or should I split it across the week?”
Most peer-reviewed work in animal models uses split daily doses for tendon and soft-tissue contexts — typical regimens are 200–500 mcg/kg per day, divided.
Pharmacokinetic data in humans is thin. Splitting is the conservative default; the half-life of subcutaneously administered BPC-157 is short.
A weekly bolus is not supported by the available literature.
Citations · 3
Research summary, not medical advice. The Companion describes what the literature shows; dose decisions stay with you and your clinician.
04 · The AI Companion · Cited. Honest about what's known and what isn't.
BPC-157 · Tendinopathy
Human-reviewed · Dr. M. Chen · 2026-04-12
02 · The Evidence Engine · Citation-rich. Plain English. Free.
Six taps a day for the inputs. Doses, vials, bloodwork ride along. Trend statements arrive with statistical honesty — never false confidence.
Pain (knee) · 0–10 (lower is better)
Insights this week · 3
Pain trend has held below 3.0 for 8 days. The dip after Day 14 aligns with peak BPC-157 timing in published animal models.
Sleep score and training volume correlate at r = 0.42 over 30 days. Harder sessions, better sleep.
23-day dosing streak. Last missed dose: Day 17 (travel). Site rotation balanced across 4 of 12 regions.
Carry one chart your clinician can actually read. Conduit produces the data; the relationship is yours.
Share with clinician03 · The Pattern Detector · Your own data, analyzed. Insights worth acting on.
Generated from your real check-ins at each milestone. You choose what to name and what to keep private. Conduit never auto-publishes anything.
05 · The Protocol Snapshot · Beautiful enough to share.
Knee pain
“Three months of consistent dosing. One site I almost gave up on.”
What we ship now, and what we’re building toward. You’re buying into a practice — not a product generation.
Today
Three minutes a day
On the way
On the wayZero minutes a day
The pen you buy today is the pen we’re integrating with tomorrow. Hardware ergonomics stay; the data layer deepens. You won’t relearn anything — the practice you build now is the practice you keep.
We don’t announce dates we can’t hold. You’ll hear from us when it ships.
The apparatus ships sterile. You source the peptide. Conduit+ supports the rest.